Evidence map›Paper›PMID 22069153›Full record

ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2011

Screening and evaluation of antiparasitic and in vitro anticancer activities of Panamanian endophytic fungi.

Sergio Martínez-Luis, Lilia Cherigo, Sarah Higginbotham, Elizabeth Arnold, Carmenza Spadafora, Alicia Ibañez, William H Gerwick, Luis Cubilla-Rios

Abstract read
In one paragraph

Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. The mitochondrial genome of the endophyteMitochondrial DNA. Part B, Resources · 2022
    Article
  3. Article
  4. Review
  5. Re-evaluation ofPersoonia · 2019
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Sergio Martínez-LuisCenter for Drug Discovery, Institute for Advanced Scientific Research and High Technology Services, Panama. smartinez@indicasat.org.pa
Lilia Cherigo
Sarah Higginbotham
Elizabeth Arnold
Carmenza Spadafora
Alicia Ibañez
William H Gerwick
Luis Cubilla-Rios
Smithsonian Institution · USUniversidad de Panamá · PACity of Knowledge · PAPlanta · RUUniversity of California, San Diego · US

Funding

ICBG: "Training, Conservation and Drug Discovery using Panamanian MicroorganismsU01TW006634 · FIC · SMITHSONIAN INSTITUTION · PI GERWICK, WILLIAM HENRY · 2003 to 2013
$7.8M
FIC NIH HHS 1U01 TW 006634-01FIC NIH HHS U01 TW006634
6 · The paper itself

Abstract

Many compounds produced by fungi have relevant pharmaceutical applications. The purpose of this study was to collect and isolate endophytic fungi from different regions of Panama and then to test their potential therapeutic activities against Leishmania donovani, Plasmodium falciparum, and Trypanosoma cruzi as well as their anticancer activities in MCF-7 cells. Of the 25 fungal isolates obtained, ten of them had good anti-parasitic potential, showing selective activity against L. donovani; four had significant anti-malarial activity; and three inhibited the growth of T. cruzi. Anticancer activity was demonstrated in four isolates. Of the active isolates, Edenia sp. strain F0755, Xylaria sp. strain F1220, Aspergillus sp. strain F1544, Mycoleptodiscus sp. strain F0194, Phomopsis sp. strain F1566, Pycnoporus sp. strain F0305, and Diaporthe sp. strain F1647 showed the most promise based on their selective bioactivity and lack of toxicity in the assays.

Indexed as

Drug Evaluation, PreclinicalAntineoplastic AgentsAntiprotozoal AgentsCell Line, TumorFungiHumansLeishmania donovaniPanamaPlasmodium falciparumTrypanosoma cruziAntineoplastic AgentsAntiprotozoal Agents

Identifiers

PMID22069153
PMCPMC3375117
OpenAlexW1827185527

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.